P2Y12 inhibitors, widely used for arterial thrombosis prevention and treatment, possess recently discovered anti-inflammatory properties, raising potential for improved sepsis prognosis.<h4>Method</h4>We conducted a retrospective analysis using the data from Medical Information Mart for Intensive Care-IV database. The gene discussed is P2RY12; the disease is Sepsis.